[go: up one dir, main page]

DK1745786T3 - Neuroprotektive forbindelser og farmaceutiske præparater, som omfatter dem - Google Patents

Neuroprotektive forbindelser og farmaceutiske præparater, som omfatter dem

Info

Publication number
DK1745786T3
DK1745786T3 DK06291167.2T DK06291167T DK1745786T3 DK 1745786 T3 DK1745786 T3 DK 1745786T3 DK 06291167 T DK06291167 T DK 06291167T DK 1745786 T3 DK1745786 T3 DK 1745786T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
neuroprotective compounds
neuroprotective
compounds
pharmaceutical
Prior art date
Application number
DK06291167.2T
Other languages
English (en)
Inventor
Marc Verleye
Guern Marie-Emmanuelle Le
Philippe Girard
Jean-Marie Gillardin
Laurence Berthon-Cedille
Bernard Hublot
Original Assignee
Biocodex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocodex filed Critical Biocodex
Application granted granted Critical
Publication of DK1745786T3 publication Critical patent/DK1745786T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK06291167.2T 2005-07-19 2006-07-18 Neuroprotektive forbindelser og farmaceutiske præparater, som omfatter dem DK1745786T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0507648A FR2888748B1 (fr) 2005-07-19 2005-07-19 Composes neuroprotecteurs et compositions pharmaceutiques les comprenant

Publications (1)

Publication Number Publication Date
DK1745786T3 true DK1745786T3 (da) 2014-03-31

Family

ID=35998417

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06291167.2T DK1745786T3 (da) 2005-07-19 2006-07-18 Neuroprotektive forbindelser og farmaceutiske præparater, som omfatter dem

Country Status (6)

Country Link
US (1) US8338410B2 (da)
EP (1) EP1745786B1 (da)
DK (1) DK1745786T3 (da)
ES (1) ES2455499T3 (da)
FR (1) FR2888748B1 (da)
PT (1) PT1745786E (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080039453A1 (en) * 2006-03-20 2008-02-14 David Putman Enantiomerically pure R-etifoxine, pharmaceutical compositions thereof and methods of their use
EP2007741A1 (en) 2006-03-20 2008-12-31 Xytis Inc. Enantiomerically pure s-etifoxine, pharmaceutical compositions thereof and methods of their use
FR2930891B1 (fr) * 2008-05-06 2010-09-24 Biocodex Composes anti-amnesiants et compositions pharmaceutiques les comprenant
AU2009289305B2 (en) * 2008-09-08 2012-08-02 F. Hoffmann-La Roche Ag 6-substituted benzoxazines as 5-HT-5A receptor antagonists
FR2937552B1 (fr) * 2008-10-27 2011-05-06 Biocodex Composition pharmaceutique destinee a la prevention ou au traitement du syndrome de sevrage alcoolique
FR2943246B1 (fr) * 2009-03-19 2011-07-29 Biocodex Compose pour son utilisation dans le traitement des neuropathies peripheriques
FR2972192A1 (fr) * 2011-03-04 2012-09-07 Biocodex Composition pharmaceutique destinee a la prevention ou au traitement des cancers
CA2979853C (en) * 2015-03-20 2021-05-11 Anvyl Llc Deuterated analogs of etifoxine, their derivatives and uses therof
FR3051114B1 (fr) * 2016-05-11 2019-09-27 Biocodex Composes pour le traitement de la maladie d'alzheimer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670772C3 (de) 1966-11-24 1978-04-20 Hoechst Ag, 6000 Frankfurt 4H-3,1-Benzoxazin-Derivate, deren Salze und pharmazeutische Präparate
DE3439055A1 (de) * 1984-10-25 1986-04-30 Hoechst Ag, 6230 Frankfurt Substituierte 4h-3,1 benzoxazine und ein benzodiazepin-derivat enthaltendes arzneimittel
EP1553946A4 (en) * 2002-10-17 2008-07-16 Merck & Co Inc SLEEP IMPROVEMENT USING T-TYPE CALCIUM CHANNEL ANTAGONISTS
AU2004230209A1 (en) * 2003-04-16 2004-10-28 F. Hoffmann-La Roche Ag Quinazoline compounds useful as p38 kinase inhibitors
EP2007741A1 (en) * 2006-03-20 2008-12-31 Xytis Inc. Enantiomerically pure s-etifoxine, pharmaceutical compositions thereof and methods of their use

Also Published As

Publication number Publication date
PT1745786E (pt) 2014-04-04
EP1745786A1 (fr) 2007-01-24
FR2888748A1 (fr) 2007-01-26
FR2888748B1 (fr) 2007-10-12
ES2455499T3 (es) 2014-04-15
US8338410B2 (en) 2012-12-25
EP1745786B1 (fr) 2014-01-01
US20070167446A1 (en) 2007-07-19

Similar Documents

Publication Publication Date Title
CY2017029I2 (el) ΑΝΤΙΚΑΡΚΙΝΙΚΟ ΦΑΡΜΑΚΟ ΠΟΥ ΠΕΡΙΕΧΕΙ α,α,α-ΤΡΙΦΘΟΡΟΘΥΜΙΔΙΝΗ ΚΑΙ ΑΝΑΣΤΟΛΕΑ ΦΩΣΦΟΡΥΛΑΣΗΣ ΘΥΜΙΔΙΝΗΣ
IL228402A0 (en) Nitro-cyclic compounds, their pharmaceutical preparations and their uses
DK3090748T3 (da) Sammensætninger, der omfatter nukleotid- og oligonukleotid-prodrugs
DK1948149T4 (da) Formulering, som omfatter metformin og vildagliptin
DK3311805T3 (da) Sammensætninger, der omfatter svært vandopløselige farmaceutiske midler og antimikrobielle midler
DK3984528T3 (da) Farmaceutiske sammensætninger, som omfatter nilotinib
RU2398586C3 (ru) Фармацевтическая композиция
IL190292A (en) History of pyridopyrimidinone and their pharmaceutical preparations
NO20075628L (no) Farmasøytiske formuleringer
BRPI0608885A2 (pt) composto de isômero c de sdz-rad, composição farmacêutica, e, embalagem farmacêutica
BRPI0511900A (pt) composições farmacêuticas
PL1913001T3 (pl) (R)-N-Metylonaltrekson, sposoby jego syntezy i jego zastosowanie farmaceutyczne
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
IL195488A (en) Compounds, pharmaceuticals containing them and their uses
NO20054329D0 (no) Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike
DK1745786T3 (da) Neuroprotektive forbindelser og farmaceutiske præparater, som omfatter dem
DK2051975T3 (da) Substituerede prolinamider, fremstilling deraf og anvendelse deraf som lægemiddel.
IL188352A0 (en) Pharmaceutical compositions
IL187534A0 (en) Thiazole derivatives, use thereof and pharmaceutical compositions containing them
NO20090724L (no) Benzylaminer, fremgangsmåte for fremstilling av slike, og anvendelse av dem som betennelseshemmende midler
ZA200804103B (en) Pharmaceutical compositions
IL218745A0 (en) Pharmaceutical compositions containing roflumilast
DK1707564T3 (da) Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DE502006001779D1 (de) Allylorganopolysiloxane aufweisende vernetzbare zusammensetzungen
BRPI0614413A2 (pt) composto, e, composição farmacêutica